Faber Logo
Skip to main content

Linda DeGraw

Director, Contracts Specialist 

Linda has dedicated more than twenty-five years to drafting, negotiating, and managing contracts in the biopharmaceutical industry, including the specialized agreements required for large, multi-center international clinical studies. 

Linda leverages her deep in-house and law firm experience to provide practical and actionable advice to clients on a wide range of agreements for the research and development of drug, medical device, and gene and cell therapy products, including master services, consulting, and clinical study site agreements.

More about Linda

Consultant to Legal Division

Warner Chilcott (now Allergan)
  • Drafted and negotiated various agreements relating to the pharmaceutical industry

Manager, Pharmaceutical Licensing & Business Development

Warner-Lambert Company (now Pfizer)
  • Evaluated licensing opportunities
  • Assisted in structuring business deals

Legal Advisor, Corporate Legal Division

Warner-Lambert Company (now Pfizer)
  • Responsible for a broad range of agreements relating to research and drug development activities

  • Supported contracting for numerous large, multinational pivotal clinical studies, including site feasibility, clinical site, master services agreements, facility use, consortium, and informed consents. Recent examples include:
    • Multiple, concurrent clinical trials of precision medicine therapeutics sponsored by IDEAYA Biosciences, Inc., including multinational Phase 2/3 trials involving over 80 sites in North America, Europe and Asia
    • Multiple concurrent clinical trials of a bifunctional monoclonal antibody that targets B cells for multiple autoimmune diseases sponsored by Zenas Biopharma (USA) LLC, including multinational Phase 3 trials involving over 100 sites in North America, South America, Europe and Asia
    • Phase 2/3 gene therapy clinical trial sponsored by bluebird bio, Inc. involving approximately 12 subjects across 5 sites in Europe and the US
  • Drafted and negotiated multi-million dollar master services agreements with global contract research organizations for large, multinational clinical studies of therapeutic, medical device and gene therapy products

  • Life Science Law Professionals, member
  • Professionals in the Pharmaceutical and Biotech Industry, member
  • Model Agreements & Guidelines International (MAGI), member

Interested in working with Linda?

Our team is eager to learn more about your project

This site uses cookies. Some provide anonymous analysis of how our website is used and some are essential to make the website work. Other cookies enable personalized services or social media features to be used. By using our website, you agree to the use of cookies. To find out more, please see our Privacy Policy. You can disable cookies at any time by changing your browser settings.